Growth of Human Tumours in Immune-suppressed Mice

Overview

Journal Proc R Soc Med

Specialty General Medicine

Date 1975 May 1

PMID 1215415

Citations 2

Authors

C R Franks

F T Perkins

J T Holmes

Affiliations

Soon will be listed here.

Citing Articles

Persistent cell mediated immune-deficiency following infantile stress during the first 6 months of life.

DUTZ W, Rossipal E, Ghavami H, Vessal K, Kohout E, Post C Eur J Pediatr. 1976; 122(2):117-30.

PMID: 817913 DOI: 10.1007/BF00466270.

Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived mice.

Franks C, Bishop D, Balkwill F, Oliver R, SPECTOR W Br J Cancer. 1977; 35(5):697-700.

PMID: 266406 PMC: 2025502. DOI: 10.1038/bjc.1977.107.

References

Franks C, Curtis K, Perkins F . Long-term survival of HeLa tumours in mice treated with antilymphocyte serum. Br J Cancer. 1973; 27(5):390-5. PMC: 2008796. DOI: 10.1038/bjc.1973.46. View

Davies A, Carter R, LEUCHARS E, Wallis V, KOLLER P . The morphology of immune reactions in normal, thymectomized and reconstituted mice. I. The response to sheep erythrocytes. Immunology. 1969; 16(1):57-69. PMC: 1409554. View

Miller J . Immunological function of the thymus. Lancet. 1961; 2(7205):748-9. DOI: 10.1016/s0140-6736(61)90693-6. View

Franks C, Perkins F, Holmes J . Subcutaneous growth of human tumours in mice. Nature. 1973; 243(5402):91. DOI: 10.1038/243091a0. View

Stanbridge E, Perkins F . Tumour nodule formation as an in vivo measure of the suppression of cellular immune response by antilymphocytic serum. Nature. 1969; 221(5175):80-1. DOI: 10.1038/221080a0. View